Skip to main navigation Skip to search Skip to main content

[Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].

  • Shugang Li*
  • , Xiaoyan Deng
  • , Hong Zhao
  • , Xiudong Huang
  • , Tinghe Yu
  • , Yong Cheng
  • , Guoping Dan
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Recombinant human interleukin-1 receptor antagonist was expressed in E. coli as an insoluble inclusion body. The inclusion body was dissolved in the 8 M urea and then the solution was diluted untill the concentration of urea became 2 M. By ion exchange chromatography the protein in the solution of 2 M urea was refolded and purified. At last the purity of product is more than 95% and its bioactivity is more than 1 x 10(5) IU/mg while it has little endotoxin. Western-Blotting also indicates that recombinant protein can react with antibodies against anti-hIL-1ra.

Original languageEnglish
Pages (from-to)1128-1132
Number of pages5
JournalShengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering
Volume24
Issue number5
StatePublished - Oct 2007

Fingerprint

Dive into the research topics of '[Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].'. Together they form a unique fingerprint.

Cite this